Professor Shen Zhongyuan, a liver disease expert from the Hubei Provincial Hospital of Traditional Chinese Medicine, pointed out that currently the treatment of hepatitis B mainly adopts antiviral immunity, enhancers, and hepatoprotective enzyme reduction drug therapies. These drugs, if used appropriately, can effectively control the condition and improve the quality of life; if used improperly, the condition may show a serious "rebound" phenomenon, and the drug efficacy may be worse.